FOXO4-DRI: Best Telehealth Providers for Longevity & Anti-Aging (2026)
A D-amino acid retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering apoptosis of these 'zombie cells.' A first-in-class senolytic peptide with potential to clear senescent cell burden.
Reviewed by Dr. James Okafor, PharmDPharmDFOXO4-DRI at a Glance
Category
Longevity & Anti-Aging
Administration
Subcutaneous injection
Telehealth Providers
2 compared
Price Range
$450 – $550/mo
Typical Dose
Investigational
Frequency
3 consecutive days, then 2-4 week break
Protocol Duration
Intermittent cycling
Prescription
Required
Research highlight: FOXO4-DRI selectively clears senescent 'zombie cells' by disrupting the FOXO4-p53 interaction that keeps them alive, as demonstrated in the landmark Nature 2017 study (van Deursen lab) showing restored fitness and organ function in aged mice.
What is FOXO4-DRI Used For?
Also known as: Senostatin, FOXO4-p53 DRI peptide
- Senescent cell clearance
- Tissue rejuvenation
- Longevity
- Age-related inflammation
How FOXO4-DRI Works
FOXO4-DRI is a D-amino acid retro-inverso peptide that disrupts the interaction between FOXO4 (a transcription factor that accumulates in senescent cells) and p53 (the tumor suppressor/apoptosis initiator) in the nuclear compartment. In normal cells, p53 triggers cell death when activated. In senescent 'zombie cells,' FOXO4 sequesters p53 in the nucleus to prevent the cell from dying — keeping it alive but in a chronically inflamed, dysfunctional state (the 'SASP': senescence-associated secretory phenotype). FOXO4-DRI disrupts this interaction, releasing p53 to trigger apoptosis specifically in senescent cells.
FOXO4-DRIDosing & Administration
| Typical Dose | Investigational |
| Frequency | 3 consecutive days, then 2-4 week break |
| Protocol Duration | Intermittent cycling |
| Route | Subcutaneous injection |
Dosing information is for educational purposes only. Your prescribing physician will determine the appropriate dose based on your medical history and treatment goals.
What to Expect from FOXO4-DRI
Animal studies (van Deursen lab, Nature 2017) show FOXO4-DRI selectively clears senescent cells, restoring fitness, fur density, and kidney function in fast-aging mice within 10 days. Human data is limited to case reports and individual patient experiences. Subjective benefits reported include improved energy, skin quality, and physical function over 4–8 weeks in early human users.
Who Should Consider FOXO4-DRI?
- Age-related chronic inflammation (inflammaging)
- Longevity optimization and senolytic protocols
- Advanced anti-aging regimens under physician supervision
FOXO4-DRI Side Effects
- Injection site reactions
- Transient fatigue (possible immune activation from cell clearance)
- Mild flu-like symptoms post-injection (immunological response to senescent cell clearance)
- Long-term safety profile in humans is not established
This is not a complete list of side effects. Always consult your prescribing physician before starting FOXO4-DRI.
2 Telehealth Providers Offering FOXO4-DRI
Sorted by lowest price. All providers require a prescription from a licensed physician.
| Provider | Price | Dose | Rating | Consultation | Lab Testing |
|---|---|---|---|---|---|
| Defy Medical Tampa, FL | $450/per-cycle | 1-2mg/day (5-day cycle) | 4.1/5 | Video Telehealth | Included |
| TruLife Health Scottsdale, AZ | $550/per-cycle | 1-2mg/day (5-day cycle) | 4.1/5 | Video Telehealth | Included |
How to Choose the Best Telehealth Provider for Longevity Peptides
Anti-aging peptide protocols are long-term investments. The right provider combines deep scientific understanding with responsible monitoring.
Biomarker-Driven Approach
Longevity medicine works best when guided by measurable biomarkers — telomere length, NAD+ levels, inflammatory markers, mitochondrial function panels. Providers who track these can adjust protocols based on objective data, not just subjective reports.
Multi-Pathway Protocol Design
Aging involves multiple hallmarks (telomere attrition, mitochondrial dysfunction, senescent cell accumulation, NAD+ decline). The best providers design protocols that address multiple hallmarks simultaneously using complementary peptides.
Physician Expertise in Longevity Medicine
Anti-aging peptides like Epithalon, FOXO4-DRI, and SS-31 operate at the frontier of research. Look for physicians with fellowship training or deep published expertise in regenerative or longevity medicine.
Safety Monitoring for Experimental Peptides
Some longevity peptides (FOXO4-DRI, SS-31) have limited long-term human safety data. Responsible providers clearly communicate experimental status, obtain informed consent, and monitor regularly for adverse effects.
Sustainable Long-Term Protocols
Anti-aging is not a one-month protocol. Look for providers offering structured long-term programs with quarterly lab reviews, dose adjustments, and clear communication about expected timelines.
Compounding Pharmacy Quality
Longevity peptides often require precise formulation and cold-chain shipping. Verify your provider works with reputable compounding pharmacies that follow USP 797/800 standards for sterile compounding.
Frequently Asked Questions About FOXO4-DRI
Is FOXO4-DRI safe for human use?
FOXO4-DRI has not completed human clinical trials. Its human use is currently experimental, based primarily on compelling mouse data and a small number of individual case reports. It is available through some compounding pharmacies and longevity-focused physicians who believe the mechanistic rationale warrants carefully supervised use. Informed consent regarding experimental status is essential.
What is a senescent cell and why do they matter?
Senescent cells are cells that have permanently stopped dividing (triggered by DNA damage, telomere shortening, or other stressors) but refuse to die. They accumulate with age and secrete inflammatory cytokines, proteases, and growth factors (the SASP) that damage surrounding healthy tissue and promote systemic inflammation — now recognized as a driver of multiple age-related diseases.
Can FOXO4-DRI be used alongside other senolytics?
Yes. Other senolytic approaches include quercetin + dasatinib (Q+D) and fisetin. Each works through different mechanisms. Combinations may produce additive senescent cell clearance, and some longevity practitioners cycle different senolytics. The safety and optimal combination protocols have not been established in human trials.
How often should FOXO4-DRI be administered?
Based on the mouse research, FOXO4-DRI was used on 3 consecutive days every 10 days. Human protocols reported by early users typically follow a similar intermittent cycle — 3 consecutive days of injection, then a break of 2–4 weeks before repeating. This intermittent approach limits total senescent cell clearance to a controlled pace.
FOXO4-DRI Alternatives for Longevity & Anti-Aging
Compare other longevity & anti-aging peptides available through telehealth.
Epithalon
A synthetic tetrapeptide studied for its ability to activate telomerase, the enzyme responsible for maintaining telomere length. Research suggests potential anti-aging effects at the cellular level.
MOTS-c
A mitochondria-derived peptide encoded within the mitochondrial genome. MOTS-c regulates metabolic homeostasis, enhances insulin sensitivity, and has shown promise in extending healthspan in animal studies. Levels naturally decline with age.
NAD+
A coenzyme found in every living cell, critical for energy metabolism and cellular repair. Levels decline with age, and supplementation is used to support longevity and cognitive function.
SS-31
A mitochondria-targeting tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin from oxidative damage. Restores mitochondrial function in aged and metabolically stressed cells, with clinical trials in heart failure and Barth syndrome.
Thymosin Alpha-1
A naturally occurring peptide first isolated from the thymus gland. FDA-orphan-drug designated, it enhances immune function by stimulating T-cell maturation and modulating cytokine production.